A novel approach to offering additional genomic findings-A protocol to test a two-step approach in the healthcare system.


Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
04 2019
Historique:
received: 27 09 2018
revised: 14 01 2019
accepted: 21 01 2019
pubmed: 19 2 2019
medline: 6 5 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

Internationally, the practice of offering additional findings (AFs) when undertaking a clinically indicated genomic test differs. In the USA, the recommendation is to include analysis for AFs alongside diagnostic analysis, unless a patient opts-out, whereas European and Canadian guidelines recommend opt-in models. These guidelines all consider the offer of AFs as an activity concurrent with the offer of diagnostic testing. This paper describes a novel two-step model for managing AFs within the healthcare system in Victoria, Australia and presents the study protocol for its evaluation. Adults who have received results of diagnostic whole exome sequencing undertaken within the healthcare system are invited to attend a genetic counseling appointment to consider reanalysis of their stored genomic data for AFs. The evaluation protocol addresses uptake, decision-making, understanding, counseling challenges, and explores preferences for future models of care. Recruitment commenced in November 2017 and will cease when 200 participants have been approached. When the study is concluded, the evaluation results will contribute to the evidence base guiding approaches to counseling and models of care for AFs.

Identifiants

pubmed: 30776170
doi: 10.1002/jgc4.1102
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

388-397

Informations de copyright

© 2019 National Society of Genetic Counselors.

Auteurs

Melissa Martyn (M)

Melbourne Genomics Health Alliance, Melbourne, Australia.
University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Anaita Kanga-Parabia (A)

Melbourne Genomics Health Alliance, Melbourne, Australia.
University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Elly Lynch (E)

Melbourne Genomics Health Alliance, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.

Paul A James (PA)

Peter MacCallum Cancer Institute, Melbourne, Australia.
The Royal Melbourne Hospital, Melbourne, Australia.

Ivan Macciocca (I)

Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.

Alison H Trainer (AH)

Peter MacCallum Cancer Institute, Melbourne, Australia.
The Royal Melbourne Hospital, Melbourne, Australia.

Jane Halliday (J)

University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Louise Keogh (L)

University of Melbourne, Melbourne, Australia.

Janney Wale (J)

Melbourne Genomics Health Alliance, Melbourne, Australia.

Ingrid Winship (I)

The Royal Melbourne Hospital, Melbourne, Australia.

Michael Bogwitz (M)

The Royal Melbourne Hospital, Melbourne, Australia.

Giulia Valente (G)

Austin Health, Melbourne, Australia.

Maie Walsh (M)

Peter MacCallum Cancer Institute, Melbourne, Australia.
The Royal Melbourne Hospital, Melbourne, Australia.

Lilian Downie (L)

University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.

David Amor (D)

University of Melbourne, Melbourne, Australia.
Royal Children's Hospital, Melbourne, Australia.

Mathew Wallis (M)

Austin Health, Melbourne, Australia.

Fiona Cunningham (F)

Murdoch Children's Research Institute, Melbourne, Australia.
Monash Health, Melbourne, Australia.

Matthew Burgess (M)

Austin Health, Melbourne, Australia.

Natasha J Brown (NJ)

University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.
Austin Health, Melbourne, Australia.
Royal Children's Hospital, Melbourne, Australia.

Anna Jarmolowicz (A)

Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.

Sebastian Lunke (S)

Murdoch Children's Research Institute, Melbourne, Australia.
Victorian Clinical Genetics Services, Melbourne, Australia.

Ilias Goranitis (I)

University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.
Melbourne Genomics Health Alliance, Melbourne, Australia.

Clara L Gaff (CL)

Melbourne Genomics Health Alliance, Melbourne, Australia.
University of Melbourne, Melbourne, Australia.
Murdoch Children's Research Institute, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH